Alps Advisors Inc Fibrogen Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$15.95 - $25.18 $28,566 - $45,097	-1,791 Reduced 2.81%	61,902 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $165,888 - $221,642	12,501 Added 24.42%	63,693 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $47,412 - $60,721	-4,159 Reduced 7.51%	51,192 $666,000
Q2 2022 Aug 11, 2022	SELL	$7.94 - $12.96 $319,457 - $521,432	-40,234 Reduced 42.09%	55,351 $585,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $140,694 - $196,526	-11,705 Reduced 10.91%	95,585 $1.15 Million
Q4 2021 Feb 09, 2022	SELL	$9.93 - $15.39 $61,853 - $95,864	-6,229 Reduced 5.49%	107,290 $1.51 Million
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $74,537 - $195,058	-7,322 Reduced 6.06%	113,519 $1.16 Million
Q2 2021 Aug 11, 2021	SELL	$18.57 - $35.68 $832,195 - $1.6 Million	-44,814 Reduced 27.05%	120,841 $3.22 Million
Q1 2021 May 07, 2021	BUY	$31.0 - $55.72 $72,509 - $130,329	2,339 Added 1.43%	165,655 $5.75 Million
Q4 2020 Feb 03, 2021	BUY	$37.09 - $48.97 $1.78 Million - $2.35 Million	48,085 Added 41.73%	163,316 $6.06 Million
Q3 2020 Nov 04, 2020	SELL	$40.47 - $45.5 $255,972 - $287,787	-6,325 Reduced 5.2%	115,231 $4.74 Million
Q2 2020 Aug 05, 2020	SELL	$32.57 - $42.83 $1.19 Million - $1.57 Million	-36,621 Reduced 23.15%	121,556 $4.93 Million
Q1 2020 May 06, 2020	SELL	$23.3 - $45.96 $408,798 - $806,368	-17,545 Reduced 9.98%	158,177 $5.5 Million
Q4 2019 Feb 07, 2020	BUY	$34.58 - $48.06 $82,922 - $115,247	2,398 Added 1.38%	175,722 $7.54 Million
Q3 2019 Nov 04, 2019	SELL	$36.98 - $48.45 $236,819 - $310,273	-6,404 Reduced 3.56%	173,324 $6.41 Million
Q2 2019 Aug 07, 2019	BUY	$35.13 - $55.53 $904,351 - $1.43 Million	25,743 Added 16.72%	179,728 $8.12 Million
Q1 2019 May 01, 2019	SELL	$42.83 - $59.91 $1.82 Million - $2.54 Million	-42,405 Reduced 21.59%	153,985 $8.37 Million
Q4 2018 Feb 04, 2019	BUY	$37.97 - $60.16 $1.79 Million - $2.84 Million	47,154 Added 31.6%	196,390 $9.09 Million
Q3 2018 Oct 25, 2018	BUY	$56.3 - $67.25 $1.61 Million - $1.92 Million	28,570 Added 23.68%	149,236 $9.07 Million
Q2 2018 Aug 02, 2018	BUY	$44.9 - $64.95 $1.34 Million - $1.93 Million	29,791 Added 32.78%	120,666 $7.55 Million
Q2 2018 Jul 25, 2018	SELL	$44.9 - $64.95 $858,398 - $1.24 Million	-19,118 Reduced 17.38%	90,875 $4.31 Million
Q1 2018 May 01, 2018	BUY	$45.35 - $61.65 $867,001 - $1.18 Million	19,118 Added 21.04%	109,993 $5.08 Million
Q4 2017 Feb 05, 2018	BUY	$41.95 - $60.1 $540,357 - $774,148	12,881 Added 16.52%	90,875 $4.31 Million
Q3 2017 Nov 03, 2017	BUY	$33.4 - $53.9 $2.6 Million - $4.2 Million	77,994	77,994 $4.2 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account